Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease. - Wikidata - awgldk - TriplyDB

Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.

Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.

http://www.wikidata.org/entity/Q37605409

about

Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.

http://www.wikidata.org/entity/Q37605409

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hyperaldosteronism and cardiov ...... ant polycystic kidney disease.

@en

Hyperaldosteronism and cardiov ...... ant polycystic kidney disease.

@nl

type

label

Hyperaldosteronism and cardiov ...... ant polycystic kidney disease.

@en

Hyperaldosteronism and cardiov ...... ant polycystic kidney disease.

@nl

prefLabel

Hyperaldosteronism and cardiov ...... ant polycystic kidney disease.

@en

Hyperaldosteronism and cardiov ...... ant polycystic kidney disease.

@nl

P1433

Q37605409-61AAE984-A5F9-494C-B5FF-627FCFEADEF6

P1476

Q37605409-507873DF-AFF6-4ED0-AEBD-992567D87EB9

P2093

Q37605409-534791A7-F18D-46BB-8DD8-7537EB3EAAC4

Q37605409-6327473F-1A9B-42C1-AC38-E3C4D992112E

Q37605409-74C3092B-AEBF-49F1-B7CE-BFE3E48E5DAA

Q37605409-7AC43CF2-5591-4DB8-8247-8BC3923C2CEC

Q37605409-8925E68F-AE14-4120-B89D-90CECB6C796C

Q37605409-926399ED-CC1F-4DCB-8D03-6FB7AB2C6C91

Q37605409-96A57585-BCA1-4F66-AEDC-D7C5A6BD4A02

Q37605409-C5ED9B71-B649-4889-93E5-1869B9ACB100

Q37605409-E5081B70-D737-4B61-9EFB-1530FA5D7545

Q37605409-FF8CA80F-637E-4802-AFE8-9CC4EF6CC284

P2860

Q37605409-03427197-7362-49FC-9B62-3E733C39B562

Q37605409-035E56FC-B923-4959-8409-65ED3A249622

Q37605409-0B786ACA-6A62-4EE3-B2AC-E707249B3C35

Q37605409-0B92BCB5-E1B0-4668-B8D1-C12188DF1683

Q37605409-1431655F-7080-4546-94CE-8CE64B4A0F93

Q37605409-19DB82F6-77BF-4048-9249-69921BE7BFCA

Q37605409-1B5B96E1-7EB1-4816-AC40-8261D127E48F

Q37605409-1BB02927-ACBF-4359-9C05-4A2383508714

Q37605409-1E0DADDE-3D23-48DF-A974-6560295BC79B

Q37605409-209FD852-51A9-4794-9FA5-ACC0ECB4D17F

P304

Q37605409-AFFD254C-C513-43A9-BFD9-D6BFE55E0AD1

P31

Q37605409-D3FAF6B3-8655-46A7-8507-1CE73D07BAC1

P356

Q37605409-D0630D7D-8E69-4E8A-8165-05851FA18329

P407

Q37605409-E6FD1021-D946-41CB-B94A-9DDFC03BB92F

P433

Q37605409-31147328-E33E-44E6-BC2A-403F8CDB790A

P478

Q37605409-5C3935A9-BAD3-4D78-8D5A-42782E00A1E8

P50

Q37605409-9E4C8E5D-B132-485F-B53E-F890827D0A26

Q37605409-B93E3BF7-AF26-4423-80A4-C9A3A75556BF

P577

Q37605409-8EA9D312-4210-4530-964E-96C2B521D59A

P698

Q37605409-EA70C3B7-A576-41F7-A0C3-45D99FA178C2

P921

Q37605409-24BAB88A-B4CA-40E6-8AFC-ECD18AD0943F

P932

Q37605409-1F8FF4E6-6CD4-4288-A56B-B9175723358F

P356

MD.0000000000004175

P1433

P1476

Hyperaldosteronism and cardiov ...... nant polycystic kidney disease

@en

P2093

Alessandro Di Gaeta

http://www.w3.org/2001/XMLSchema#string

Anna Rita D'Angelo

http://www.w3.org/2001/XMLSchema#string

Claudio Letizia

http://www.w3.org/2001/XMLSchema#string

Daniela Mastroluca

http://www.w3.org/2001/XMLSchema#string

Elena Indino

http://www.w3.org/2001/XMLSchema#string

Emanuela Petraglia

http://www.w3.org/2001/XMLSchema#string

Hossein H Shahabadi

http://www.w3.org/2001/XMLSchema#string

Mauro Ciccariello

http://www.w3.org/2001/XMLSchema#string

Silvia Lai

http://www.w3.org/2001/XMLSchema#string

Valeria Panebianco

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Vascular disturbances in primary aldosteronism: clinical evidence

Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein

Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells

Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Uricemia and homocysteinemia: nontraditional risk factors in the early stages of chronic kidney disease--preliminary data.

P304

e4175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000004175

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Luigi Petramala

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27442639

http://www.w3.org/2001/XMLSchema#string

P921

autosomal dominant polycystic kidney disease

P932

5265756

http://www.w3.org/2001/XMLSchema#string